McKesson Corporation (BVMF:M1CK34)

Market Cap	606.51B +35.2%
Revenue (ttm)	2.19T +15.5%
Net Income	23.90B +53.6%
EPS	191.37 +59.2%
Shares Out	n/a
PE Ratio	25.37
Forward PE	22.05
Dividend	2.83 (0.23%)
Ex-Dividend Date	Nov 28, 2025

Volume	9
Average Volume	60
Open	1,256.67
Previous Close	1,274.00
Day's Range	1,244.00 - 1,256.67
52-Week Range	797.74 - 1,274.64
Beta	0.41
RSI	69.36
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: M1CK34

Financial Performance

In fiscal year 2025, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD